Thursday, 2 September 2021

DRL, Natco rise on nod for Revlimid copy

Shares of Dr. Reddy’s Laboratories and Natco Pharma gained almost 2% and more than 4%, respectively on Thursday after the drugmakers announced the unv

from The Hindu - Home https://ift.tt/2WNutJ7
via IFTTT

No comments:

Post a Comment